Request an Appointment Today
*
*
*
*
*
*
*

Precision therapy for blood cancers and disorders

Since 1977, the blood and marrow transplantation experts at The University of Kansas Cancer Center in Kansas City have dedicated themselves to treating blood cancers and blood disorders with lifesaving stem cell transplants. A leader in the advancement of precision cancer therapies, the team has performed more than 3,400 transplants.

What is a blood and marrow transplant?

A blood and marrow transplant (BMT) infuses healthy bone marrow or peripheral blood stem cells into patients fighting blood cancers and disorders such as leukemia, lymphoma, myeloma or sickle cell disease. The procedure rebuilds a healthy blood supply.

Depending upon a patient’s unique condition, a transplant may be autologous – using the patient’s own cells – or allogeneic – using stem cells provided by a donor. Donated cells can come from a relative, an unknown donor, or cord blood that has been previously collected and stored.

Why choose The University of Kansas Cancer Center?

  • Our BMT program, the region’s largest, provides comprehensive inpatient and outpatient care for patients undergoing transplant. Through more than 3,400 transplant procedures performed since our inception, we have built unmatched experience.

  • As a National Cancer Institute-designated cancer center, we offer access to the latest treatment and clinical trials. These include exciting developments in precision cancer therapies such as CAR T-cell therapy, in which a patient’s own white blood cells are extracted, modified in a laboratory, and reinfused into the patient, supercharged to seek and destroy cancer cells.

  • We offer the complete care team patients need to navigate a cancer diagnosis and stem cell transplant. Our physicians are among the nation’s best and most experienced, and their work is complemented by that of specially trained nurses, pharmacists, dietitians, financial counselors and more. This focused and compassionate team is entirely dedicated to the physical, mental and emotional needs of BMT patients and their caregivers.

  • We are the region’s first BMT program to earn accreditation by the Foundation for Accreditation of Cellular Therapy, and we have been a member of the National Marrow Donor Program since 1995. Distinctions such as these offer patients confidence in the world-class care available to them, right here in Kansas City.